AVE 0991 Suppresses Astrocyte-Mediated Neuroinflammation of Alzheimer’s Disease by Enhancing Autophagy

References

• Matej R, Tesar A, Rusina R. Alzheimer’s disease and other neurodegenerative dementias in comorbidity: a clinical and neuropathological overview. Clin Biochem. 2019;73:26–31. doi:10.1016/j.clinbiochem.2019.08.005
   PubMed Web of Science ®Google Scholar
• Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353–356. doi:10.1126/science.1072994
   PubMed Web of Science ®Google Scholar
• Braak H, Del Tredici K. The preclinical phase of the pathological process underlying sporadic Alzheimer’s disease. Brain. 2015;138(Pt 10):2814–2833. doi:10.1093/brain/awv236
   PubMedGoogle Scholar
• Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci. 2015;16(6):358–372. doi:10.1038/nrn3880
   PubMed Web of Science ®Google Scholar
• Sala Frigerio C, Wolfs L, Fattorelli N, et al. The major risk factors for Alzheimer’s disease: age, sex, and genes modulate the microglia response to Aβ plaques. Cell Rep. 2019;27(4):1293–1306.e6. doi:10.1016/j.celrep.2019.03.099
   PubMed Web of Science ®Google Scholar
• Heneka MT, Carson MJ, El Khoury J, et al. Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 2015;14(4):388–405. doi:10.1016/S1474-4422(15)70016-5
   PubMed Web of Science ®Google Scholar
• Rossi D. Astrocyte physiopathology: at the crossroads of intercellular networking, inflammation and cell death. Prog Neurobiol. 2015;130. doi:10.1016/j.pneurobio.2015.04.003
   Web of Science ®Google Scholar
• Ledo JH, Azevedo EP, Beckman D, et al. Cross talk between brain innate immunity and serotonin signaling underlies depressive-like behavior induced by Alzheimer’s Amyloid-β oligomers in mice. J Neurosci. 2016;36(48):12106–12116. doi:10.1523/JNEUROSCI.1269-16.2016
   Web of Science ®Google Scholar
• Lourenco MV, Clarke JR, Frozza RL, et al. TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer’s β-amyloid oligomers in mice and monkeys. Cell Metab. 2013;18(6):831–843. doi:10.1016/j.cmet.2013.11.002
   PubMed Web of Science ®Google Scholar
• Bomfim TR, Forny-Germano L, Sathler LB, et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease- associated Aβ oligomers. J Clin Invest. 2012;122(4):1339–1353. doi:10.1172/JCI57256
   PubMed Web of Science ®Google Scholar
• Colombo E, Farina C. Astrocytes: key regulators of neuroinflammation. Trends Immunol. 2016;37(9):608–620. doi:10.1016/j.it.2016.06.006
   PubMed Web of Science ®Google Scholar
• Clarke LE, Barres BA. Emerging roles of astrocytes in neural circuit development. Nat Rev Neurosci. 2013;14(5):311–321. doi:10.1038/nrn3484
   PubMed Web of Science ®Google Scholar
• Chung W-S, Clarke LE, Wang GX, et al. Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature. 2013;504(7480):394–400. doi:10.1038/nature12776
   PubMed Web of Science ®Google Scholar
• Liddelow S, Barres B. SnapShot: astrocytes in Health and Disease. Cell. 2015;162(5):1170–1170.e1. doi:10.1016/j.cell.2015.08.029
   Web of Science ®Google Scholar
• Choi M, Kim H, Yang E-J, Kim H-S. Inhibition of STAT3 phosphorylation attenuates impairments in learning and memory in 5XFAD mice, an animal model of Alzheimer’s disease. J Pharmacol Sci. 2020;143(4):290–299. doi:10.1016/j.jphs.2020.05.009
   PubMed Web of Science ®Google Scholar
• Liu L, Martin R, Chan C. Palmitate-activated astrocytes via serine palmitoyltransferase increase BACE1 in primary neurons by sphingomyelinases. Neurobiol Aging. 2013;34(2):540–550. doi:10.1016/j.neurobiolaging.2012.05.017
   PubMed Web of Science ®Google Scholar
• Habib N, McCabe C, Medina S, et al. Disease-associated astrocytes in Alzheimer’s disease and aging. Nat Neurosci. 2020;23(6):701–706. doi:10.1038/s41593-020-0624-8
   PubMed Web of Science ®Google Scholar
• Wang J-L, Xu C-J. Astrocytes autophagy in aging and neurodegenerative disorders. Biomed Pharmacother. 2020;122:109691. doi:10.1016/j.biopha.2019.109691
   PubMed Web of Science ®Google Scholar
• Ravanan P, Srikumar IF, Talwar P. Autophagy: the spotlight for cellular stress responses. Life Sci. 2017;188:53–67. doi:10.1016/j.lfs.2017.08.029
   PubMed Web of Science ®Google Scholar
• Wolfe DM, Lee J-H, Kumar A, Lee S, Orenstein SJ, Nixon RA. Autophagy failure in Alzheimer’s disease and the role of defective lysosomal acidification. Eur J Neurosci. 2013;37(12):1949–1961. doi:10.1111/ejn.12169
   PubMed Web of Science ®Google Scholar
• Hong Y, Liu Y, Zhang G, Wu H, Hou Y. Progesterone suppresses Aβ-induced neuroinflammation by enhancing autophagy in astrocytes. Int Immunopharmacol. 2018;54:336–343. doi:10.1016/j.intimp.2017.11.044
   Web of Science ®Google Scholar
• Jiang T, Gao L, Zhu X-C, et al. Angiotensin-(1-7) inhibits autophagy in the brain of spontaneously hypertensive rats. Pharmacol Res. 2013;71:61–68. doi:10.1016/j.phrs.2013.03.001
   Web of Science ®Google Scholar
• Gao Q, Chen R, Wu L, et al. Angiotensin-(1-7) reduces α-synuclein aggregation by enhancing autophagic activity in Parkinson’s disease. Neural Regen Res. 2022;17(5):1138–1145. doi:10.4103/1673-5374.324854
   Web of Science ®Google Scholar
• Jiang T, Xue L-J, Yang Y, et al. AVE0991, a nonpeptide analogue of Ang-(1-7), attenuates aging-related neuroinflammation. Aging. 2018;10(4):645–657. doi:10.18632/aging.101419
   PubMedGoogle Scholar
• Dang R, Yang M, Cui C, et al. Activation of angiotensin-converting enzyme 2/angiotensin (1-7)/mas receptor axis triggers autophagy and suppresses microglia proinflammatory polarization via forkhead box class O1 signaling. Aging Cell. 2021;20(10):e13480. doi:10.1111/acel.13480
   PubMed Web of Science ®Google Scholar
• Yu J-Z, Li Y-H, Liu C-Y, et al. Multitarget therapeutic effect of fasudil in APP/PS1transgenic mice. CNS Neurol Disord Drug Targets. 2017;16(2):199–209. doi:10.2174/1871527315666160711104719
   PubMed Web of Science ®Google Scholar
• Jiang T, Yu J-T, Zhu X-C, et al. Triggering receptor expressed on myeloid cells 2 knockdown exacerbates aging-related neuroinflammation and cognitive deficiency in senescence-accelerated mouse prone 8 mice. Neurobiol Aging. 2014;35(6):1243–1251. doi:10.1016/j.neurobiolaging.2013.11.026
   Web of Science ®Google Scholar
• Klein WL. Abeta toxicity in Alzheimer’s disease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem Int. 2002;41(5):345–352. doi:10.1016/S0197-0186(02)00050-5
   PubMed Web of Science ®Google Scholar
• Liu B, Liu J, Wang J, et al. Adiponectin protects against cerebral ischemic injury through AdipoR1/AMPK pathways. Front Pharmacol. 2019;10:597. doi:10.3389/fphar.2019.00597
   Web of Science ®Google Scholar
• Bandyopadhyay S. Role of neuron and glia in Alzheimer’s disease and associated vascular dysfunction. Front Aging Neurosci. 2021;13:653334. doi:10.3389/fnagi.2021.653334
   Web of Science ®Google Scholar
• Santos RAS, Simoes e Silva AC, Maric C, et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A. 2003;100(14):8258–8263. doi:10.1073/pnas.1432869100
   PubMed Web of Science ®Google Scholar
• Lee S, Evans MA, Chu HX, et al. Effect of a selective mas receptor agonist in cerebral ischemia in vitro and in vivo. PLoS One. 2015;10(11):e0142087. doi:10.1371/journal.pone.0142087
   Web of Science ®Google Scholar
• Mo J, Enkhjargal B, Travis ZD, et al. AVE 0991 attenuates oxidative stress and neuronal apoptosis via Mas/PKA/CREB/UCP-2 pathway after subarachnoid hemorrhage in rats. Redox Biol. 2019;20:75–86. doi:10.1016/j.redox.2018.09.022
   PubMed Web of Science ®Google Scholar
• Xue X, Duan R, Zhang -Q-Q, et al. A Non-Peptidic MAS1 agonist AVE0991 alleviates hippocampal synaptic degeneration in rats with chronic cerebral hypoperfusion. Curr Neurovasc Res. 2021;18(3):343–350. doi:10.2174/1567202618666211012095210
   Web of Science ®Google Scholar
• Saito T, Saido TC. Neuroinflammation in mouse models of Alzheimer’s disease. Clin Exp Neuroimmunol. 2018;9(4):211–218. doi:10.1111/cen3.12475
   PubMedGoogle Scholar
• Kempuraj D, Thangavel R, Natteru PA, et al. Neuroinflammation induces neurodegeneration. J Neurol Neurosurg Spine. 2016;1(1):1003.
   PubMedGoogle Scholar
• Russo MV, McGavern DB. Inflammatory neuroprotection following traumatic brain injury. Science. 2016;353(6301):783–785. doi:10.1126/science.aaf6260
   PubMed Web of Science ®Google Scholar
• Krabbe G, Halle A, Matyash V, et al. Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS One. 2013;8(4):e60921. doi:10.1371/journal.pone.0060921
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhu X, Tong H, et al. AVE 0991 attenuates pyroptosis and liver damage after heatstroke by inhibiting the ROS-NLRP3 inflammatory signalling pathway. Biomed Res Int. 2019;2019:1806234. doi:10.1155/2019/1806234
   PubMed Web of Science ®Google Scholar
• Barroso LC, Silveira KD, Lima CX, et al. Renoprotective effects of AVE0991, a nonpeptide mas receptor agonist, in experimental acute renal injury. Int J Hypertens. 2012;2012:808726. doi:10.1155/2012/808726
   Google Scholar
• Wang Z, Huang W, Ren F, et al. Characteristics of Ang-(1-7)/Mas-mediated amelioration of joint inflammation and cardiac complications in mice with collagen-induced arthritis. Front Immunol. 2021;12:655614. doi:10.3389/fimmu.2021.655614
   Web of Science ®Google Scholar
• Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer’s disease. Neurobiol Aging. 2000;21(3):383–421. doi:10.1016/S0197-4580(00)00124-X
   PubMed Web of Science ®Google Scholar
• Spangenberg EE, Green KN. Inflammation in Alzheimer’s disease: lessons learned from microglia-depletion models. Brain Behav Immun. 2017;61. doi:10.1016/j.bbi.2016.07.003
   Web of Science ®Google Scholar
• Rodríguez-Arellano JJ, Parpura V, Zorec R, Verkhratsky A. Astrocytes in physiological aging and Alzheimer’s disease. Neuroscience. 2016;323:170–182. doi:10.1016/j.neuroscience.2015.01.007
   PubMed Web of Science ®Google Scholar
• Kato S, Gondo T, Hoshii Y, Takahashi M, Yamada M, Ishihara T. Confocal observation of senile plaques in Alzheimer’s disease: senile plaque morphology and relationship between senile plaques and astrocytes. Pathol Int. 1998;48(5):332–340. doi:10.1111/j.1440-1827.1998.tb03915.x
   Web of Science ®Google Scholar
• Simpson JE, Ince PG, Lace G, et al. Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiol Aging. 2010;31(4):578–590. doi:10.1016/j.neurobiolaging.2008.05.015
   Web of Science ®Google Scholar
• Kamphuis W, Middeldorp J, Kooijman L, et al. Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer’s disease. Neurobiol Aging. 2014;35(3):492–510. doi:10.1016/j.neurobiolaging.2013.09.035
   Web of Science ®Google Scholar
• Medeiros R, LaFerla FM. Astrocytes: conductors of the Alzheimer disease neuroinflammatory symphony. Exp Neurol. 2013;239:133–138. doi:10.1016/j.expneurol.2012.10.007
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhang S, Peng Y, et al. Safflower leaf ameliorates cognitive impairment through moderating excessive astrocyte activation in APP/PS1 mice. Food Funct. 2021;12(22):11704–11716. doi:10.1039/D1FO01755A
   Web of Science ®Google Scholar
• Huo Q, Shi Y, Qi Y, Huang L, Sui H, Zhao L. Biomimetic silibinin-loaded macrophage-derived exosomes induce dual inhibition of Aβ aggregation and astrocyte activation to alleviate cognitive impairment in a model of Alzheimer’s disease. Mater Sci Eng C Mater Biol Appl. 2021;129:112365. doi:10.1016/j.msec.2021.112365
   PubMed Web of Science ®Google Scholar
• Carroll B, Hewitt G, Korolchuk VI, Lane JD. Autophagy and ageing: implications for age-related neurodegenerative diseases. Essays Biochem. 2013;55:119–131. doi:10.1042/bse0550119
   Web of Science ®Google Scholar
• Nilsson P, Loganathan K, Sekiguchi M, et al. Aβ secretion and plaque formation depend on autophagy. Cell Rep. 2013;5(1):61–69. doi:10.1016/j.celrep.2013.08.042
   PubMed Web of Science ®Google Scholar
• Wang Y, Mandelkow E. Degradation of tau protein by autophagy and proteasomal pathways. Biochem Soc Trans. 2012;40(4):644–652. doi:10.1042/BST20120071
   Google Scholar
• Ghavami S, Shojaei S, Yeganeh B, et al. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol. 2014;112:24–49. doi:10.1016/j.pneurobio.2013.10.004
   PubMed Web of Science ®Google Scholar
• Kong Y, Zhao X, Qiu M, et al. Tubular Mas receptor mediates lipid-induced kidney injury. Cell Death Dis. 2021;12(1):110. doi:10.1038/s41419-020-03375-z
   Web of Science ®Google Scholar
• Cadwell K. Crosstalk between autophagy and inflammatory signalling pathways: balancing defence and homeostasis. Nat Rev Immunol. 2016;16(11):661–675. doi:10.1038/nri.2016.100
   PubMed Web of Science ®Google Scholar